UVa Cancer Center seeks adults ages 18 and older with breast cancer for research study.


15881

Breast 41: A Pilot Study of the Immunogenicity of a 9-Peptide Breast Cancer Vaccine plus Poly-ICLC in Stage IB-IV Breast Cancer

Medicine

Dillon Patrick, M

UVa Cancer Center seeks adults ages 18 and older with breast cancer for research study. The purpose of this study is to find out how the “body” (immune system) of participants changes when given a breast cancer vaccine. We also want to find out the side effects of the vaccine. The study involves 9 study visits over three and a half months that include blood draws and receiving an experimental vaccine. * Experimental vaccine will be provided free of charge * No compensation is provided for this study. Contact Information: For more information please contact: • Emily Allred • (434) 982-1902, eh4m@virginia.edu • IRB-HSR # 15881 Principal Investigator: Patrick Dillon, MD


Adult

Breast Cancer

Women's Health
Cancer (Oncology)

Ill

No Compensation

Emily Allred

eh4m@virginia.edu

4349821902